Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice

Lauren M. Aleksunes and Curtis D. Klaassen
Drug Metabolism and Disposition July 2012, 40 (7) 1366-1379; DOI: https://doi.org/10.1124/dmd.112.045112
Lauren M. Aleksunes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis D. Klaassen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 40 no. 7 1366-1379
DOI 
https://doi.org/10.1124/dmd.112.045112
PubMed 
22496397

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 16, 2012
  • Accepted April 11, 2012
  • Published online June 20, 2012.

Article Versions

  • Earlier version (April 11, 2012 - 08:48).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lauren M. Aleksunes and
  2. Curtis D. Klaassen
  1. Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (L.M.A., C.D.K.); and Department of Pharmacology and Toxicology, Rutgers University, Ernest Mario School of Pharmacy and Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey (L.M.A.)
  1. Address correspondence to:
    Dr. Curtis Klaassen, Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7417. E-mail: cklaasse{at}kumc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: April 2012 to January 2021

AbstractFullPdf
Apr 20124100232
May 20121750150
Jun 201238920151
Jul 20123126096
Aug 20121423149
Sep 20121252542
Oct 2012813946
Nov 2012672732
Dec 2012731724
Jan 20131774653
Feb 2013795543
Mar 2013892733
Apr 2013734137
May 2013624848
Jun 2013472738
Jul 2013555949
Aug 2013344061
Sep 2013836450
Oct 2013624963
Nov 2013294658
Dec 2013273431
Jan 2014323834
Feb 2014283235
Mar 2014432827
Apr 2014232420
May 2014383545
Jun 2014423122
Jul 2014394757
Aug 2014194031
Sep 2014402130
Oct 2014332635
Nov 2014353542
Dec 2014311920
Jan 2015392018
Feb 2015832637
Mar 2015402530
Apr 2015331627
May 2015322323
Jun 2015271720
Jul 2015472146
Aug 2015192422
Sep 2015361721
Oct 2015512533
Nov 20151629195
Dec 2015602131
Jan 2016381627
Feb 2016292628
Mar 2016231934
Apr 2016261441
May 2016292749
Jun 2016211935
Jul 2016152342
Aug 2016252239
Sep 2016142548
Oct 2016282631
Nov 2016221917
Dec 2016103616
Jan 2017113022
Feb 201735249
Mar 2017283928
Apr 2017153522
May 201751924
Jun 201762736
Jul 201733626
Aug 2017122723
Sep 201743020
Oct 201742620
Nov 201764926
Dec 2017152427
Jan 201842427
Feb 201892224
Mar 201882315
Apr 201883614
May 201863632
Jun 201833316
Jul 201821921
Aug 2018122323
Sep 201884317
Oct 201812516
Nov 2018122538
Dec 2018321119
Jan 201935211
Feb 201946313
Mar 20192459
Apr 201928119
May 201953815
Jun 201928414
Jul 20192558
Aug 20193479
Sep 20193817
Oct 20195424
Nov 20193712
Dec 20195166
Jan 20203754
Feb 20203024
Mar 20203991
Apr 20201571
May 20202674
Jun 20202864
Jul 20202112
Aug 20204556
Sep 20204892
Oct 202044139
Nov 20202875
Dec 2020511211
Jan 202119127

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (7)
Drug Metabolism and Disposition
Vol. 40, Issue 7
1 Jul 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

TRANSCRIPTION FACTOR-GENE INTERACTIONS

Lauren M. Aleksunes and Curtis D. Klaassen
Drug Metabolism and Disposition July 1, 2012, 40 (7) 1366-1379; DOI: https://doi.org/10.1124/dmd.112.045112

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

TRANSCRIPTION FACTOR-GENE INTERACTIONS

Lauren M. Aleksunes and Curtis D. Klaassen
Drug Metabolism and Disposition July 1, 2012, 40 (7) 1366-1379; DOI: https://doi.org/10.1124/dmd.112.045112
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics